NCT00899418View on ClinicalTrials.gov

Studying Tumor Tissue Samples to Learn More About DNA Changes and Response in Patients With Breast Cancer Treated With Bevacizumab on Clinical Trial ECOG-2100

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

November 30, 2006

Conditions
Breast Cancer
Interventions
GENETIC

gene expression analysis

GENETIC

polymerase chain reaction

GENETIC

polymorphism analysis

OTHER

immunohistochemistry staining method

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00899418 - Studying Tumor Tissue Samples to Learn More About DNA Changes and Response in Patients With Breast Cancer Treated With Bevacizumab on Clinical Trial ECOG-2100 | Biotech Hunter | Biotech Hunter